3,0
23. Juli 2014
Aktueller Mitarbeiter, mehr als 8 Jahre
South San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great Benefits Intelligent people. Great projects, pipeline and opportunities to collaborate with Roche and other partners.
Kontras
Politics. Easier to come from the outside in then to be promoted in current position. It is big pharma now.